DOI: 10.1007/s00259-018-4026-zPages: 1362-1363

Alphatherapy, the new impetus to targeted radionuclide therapy?

1. Groupement d’Intérêt Public Arronax and University of Nantes

2. ICO-CHU Nantes-UN-CRCINA

Correspondence to:
Jean-François Chatal
Email: jean-francois.chatal@univ-nantes.fr

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Online: Apr 25, 2018

Article Tools

eanm
EJNMMI Ad